Management of Infection After Intramedullary Nailing of Long Bone Fractures: Treatment Protocols and Outcomes
Overview
Affiliations
Implant related sepsis is a relatively unusual complication of intra-medullary nail fixation of long bone fractures. Depending on the extent of infection, timing of diagnosis and progress of fracture union, different treatment strategies have been developed. The aim of this review article is to collect and analyze the existing evidence about the incidence and management of infection following IM nailing of long bone fractures and to recommend treatment algorithms that could be valuable in everyday clinical practice. After searching the P u b M e d /Medline databases, 1270 articles were found related to the topic during the last 20 years. The final review included 28 articles that fulfilled the inclusion criteria. Only a few prospective studies exist to report on the management of infection following IM nailing of long-bone fractures. In general, stage I (early) infections only require antibiotic administration with/without debridement. Stage II (delayed) infections can be successfully treated with debridement, IM reaming, antibiotic nails, and administration of antibiotics. Infected non-unions are best treated with exchange nailing, antibiotic administration and when infection has been eradicated with graft implantation if it is needed. Debridement, exchange nailing and systemic administration of antibiotics is the best indication for stage III (late) infections, while stage III infected non-unions can successfully be treated with nail removal and Ilizarov frame, especially when large bone defects exist.
Zhou Z, Qin H, Marei A, Wen J, Yu L, Meng F Plast Reconstr Surg Glob Open. 2024; 12(12):e6346.
PMID: 39687414 PMC: 11649285. DOI: 10.1097/GOX.0000000000006346.
Kashyap S, Ambade R, Landge S, Salwan A Cureus. 2024; 16(10):e70978.
PMID: 39507186 PMC: 11539009. DOI: 10.7759/cureus.70978.
Adesina S, Amole I, Akinwumi A, Adegoke A, Owolabi J, Adefokun I J Bone Jt Infect. 2024; 8(1):71-79.
PMID: 38774303 PMC: 11106765. DOI: 10.5194/jbji-8-71-2023.
Ann Azad M, Patel R Clin Microbiol Rev. 2024; 37(2):e0010423.
PMID: 38506553 PMC: 11237642. DOI: 10.1128/cmr.00104-23.
Ghaseminejad-Raeini A, Azarboo A, Pirahesh K, Sharafi A, Hoveidaei A, Nwankwo B Antibiotics (Basel). 2024; 13(1).
PMID: 38247628 PMC: 10812602. DOI: 10.3390/antibiotics13010069.